Skip to main content

Published locations for Early Analysis Supports Erlotinib for First-Line Treatment of NSCLC With EGFR Mutation

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Early Analysis Supports Erlotinib for First-Line Treatment of NSCLC With EGFR Mutation

User login

  • Reset your password
  • /content/early-analysis-supports-erlotinib-first-line-treatment-nsclc-egfr-mutation
  • /internalmedicinenews/article/20270/oncology/early-analysis-supports-erlotinib-first-line-treatment
  • /internalmedicine/article/20270/oncology/early-analysis-supports-erlotinib-first-line-treatment-nsclc